Origins and pathogenesis of Middle East respiratory syndrome-associated coronavirus: Recent advances

F1000Research

Volumn 6, Issue , 2017, Pages

  Weiss, Susan R ^a   Goldstein, Stephen A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CoV; MERS; Origin; Pathogenesis

Indexed keywords

VIRAL PROTEIN;

BAT; CALLITHRIX JACCHUS; CAMEL; DISEASE CARRIER; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RHESUS MONKEY;

EID: 85028974523     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.11827.1     Document Type: Review

References (70)

1. Zaki AM van Boheemen S Bestebroer TM: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(9):1814-20. 23075143 10.1056/NEJMoa1211721 F1000 Recommendation
2. Al-Abdallat MM Payne DC Alqasrawi S: Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014;59(9):1225-33. 24829216 10.1093/cid/ciu359 4834865
3. Cho SY Kang JM Ha YE: MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet. 2016;388(10048):994-1001. 27402381 10.1016/S0140-6736(16)30623-7 F1000 Recommendation
4. van Boheemen S de Graaf M Lauber C: Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio. 2012;3(6): pii: e00473-12. 23170002 10.1128/mBio.00473-12 3509437 F1000 Recommendation
5. Müller MA Meyer B Corman VM: Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15(5):559-64. 25863564 10.1016/S1473-3099(15)70090-3 F1000 Recommendation
6. Liljander A Meyer B Jores J: MERS-CoV Antibodies in Humans, Africa, 2013-2014. Emerg Infect Dis. 2016;22(6):1086-9. 27071076 10.3201/eid2206.160064 4880087 F1000 Recommendation
7. Woo PC Wang M Lau SK: Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol. 2007;81(4):1574-85. 17121802 10.1128/JVI.02182-06 1797546
8. De Benedictis P Marciano S Scaravelli D: Alpha and lineage C betaCoV infections in Italian bats. Virus Genes. 2014;48(2):366-71. 24242847 10.1007/s11262-013-1008-x
9. Lelli D Papetti A Sabelli C: Detection of coronaviruses in bats of various species in Italy. Viruses. 2013;5(11):2679-89. 24184965 10.3390/v5112679 3856409
10. Anthony SJ Ojeda-Flores R Rico-Chávez O: Coronaviruses in bats from Mexico. J Gen Virol. 2013;94(pt 5):1028-38. 23364191 10.1099/vir.0.049759-0 3709589
11. Góes LG Ruvalcaba SG Campos AA: Novel bat coronaviruses, Brazil and Mexico. Emerg Infect Dis. 2013;19(10):1711-3. 24050144 10.3201/eid1910.130525 3810755
12. Wacharapluesadee S Sintunawa C Kaewpom T: Group C betacoronavirus in bat guano fertilizer, Thailand. Emerg Infect Dis. 2013;19(8):1349-51. 23880503 10.3201/eid1908.130119 3739538
13. Anthony SJ Johnson CK Greig DJ: Global patterns in coronavirus diversity. Virus Evol. 2017;3(1):vex012. 28630747 10.1093/ve/vex012 5467638 F1000 Recommendation
14. Memish ZA Mishra N Olival KJ: Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis. 2013;19(11):1819-23. 24206838 10.3201/eid1911.131172 3837665
15. Ithete NL Stoffberg S Corman VM: Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis. 2013;19(10):1697-9. 24050621 10.3201/eid1910.130946 3810765
16. Annan A Baldwin HJ Corman VM: Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis. 2013;19(3):456-9. 23622767 10.3201/eid1903.121503 3647674
17. Corman VM Ithete NL Richards LR: Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol. 2014;88(19):11297-303. 25031349 10.1128/JVI.01498-14 4178802
18. Anthony SJ Gilardi K Menachery VD: Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus. mBio. 2017;8(2): pii: e00373-17. 28377531 10.1128/mBio.00373-17 5380844 F1000 Recommendation
19. Memish ZA Cotten M Meyer B: Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis. 2014;20(6):1012-5. 24857749 10.3201/eid2006.140402 4036761
20. Raj VS Farag EA Reusken CB: Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis. 2014;20(8):1339-42. 25075761 10.3201/eid2008.140663 4111206
21. Chan RW Hemida MG Kayali G: Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014;2(10):813-22. 25174549 10.1016/S2213-2600(14)70158-4
22. Reusken CB Farag EA Haagmans BL: Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014. Emerg Infect Dis. 2015;21(8):1422-5. 26196891 10.3201/eid2108.150481 4517733 F1000 Recommendation
23. Farag EA Reusken CB Haagmans BL: High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014. Infect Ecol Epidemiol. 2015;5: 28305. 26183160 10.3402/iee.v5.28305 4505336 F1000 Recommendation
24. Saeed AA Abedi GR Alzahrani AG: Surveillance and Testing for Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, April 2015-February 2016. Emerg Infect Dis. 2017;23(4):682-5. 28322710 10.3201/eid2304.161793 5367404 F1000 Recommendation
25. Müller MA Corman VM Jores J: MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis. 2014;20(12):2093-5. 25425139 10.3201/eid2012.141026 4257824 F1000 Recommendation
26. Corman VM Jores J Meyer B: Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis. 2014;20(8):1319-22. 25075637 10.3201/eid2008.140596 4111164
27. Reusken CB Messadi L Feyisa A: Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis. 2014;20(8):1370-4. 25062254 10.3201/eid2008.140590 4111168
28. Miguel E Chevalier V Ayelet G: Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015. Euro Surveill. 2017;22(13): pii: 30498. 28382915 10.2807/1560-7917.ES.2017.22.13.30498 5388105 F1000 Recommendation
29. Sabir JS Lam TT Ahmed MM: Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science. 2016;351(6268):81-4. 26678874 10.1126/science.aac8608 F1000 Recommendation
30. Ng DL Al Hosani F Keating MK: Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014. Am J Pathol. 2016;186(3):652-8. 26857507 10.1016/j.ajpath.2015.10.024 F1000 Recommendation
31. de Wit E Rasmussen AL Falzarano D: Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A. 2013;110(41):16598-603. 24062443 10.1073/pnas.1310744110 3799368
32. Yao Y Bao L Deng W: An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J Infect Dis. 2014;209(2):236-42. 24218506 10.1093/infdis/jit590
33. Scobey T Yount BL Sims AC: Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci U S A. 2013;110(40):16157-62. 24043791 10.1073/pnas.1311542110 3791741
34. Falzarano D de Wit E Feldmann F: Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 2014;10(8):e1004250. 25144235 10.1371/journal.ppat.1004250 4140844
35. Baseler LJ Falzarano D Scott DP: An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity. Am J Pathol. 2016;186(3):630-8. 26724387 10.1016/j.ajpath.2015.10.025 4816712 F1000 Recommendation
36. Yu P Xu Y Deng W: Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus. PLoS One. 2017;12(2):e0172093. 28234937 10.1371/journal.pone.0172093 5325479 F1000 Recommendation
37. Johnson RF Via LE Kumar MR: Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease. Virology. 2015;485:422-30. 26342468 10.1016/j.virol.2015.07.013 5001852 F1000 Recommendation
38. Cockrell AS Peck KM Yount BL: Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection. J Virol. 2014;88(9):5195-9. 24574399 10.1128/JVI.03764-13 3993820
39. Peck KM Cockrell AS Yount BL: Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection. J Virol. 2015;89(8):4696-9. 25653445 10.1128/JVI.03445-14 4442375 F1000 Recommendation
40. Cockrell AS Yount BL Scobey T: A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat Microbiol. 2016;2: 16226. 27892925 10.1038/nmicrobiol.2016.226 F1000 Recommendation
41. Zhao J Li K Wohlford-Lenane C: Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A. 2014;111(13):4970-5. 24599590 10.1073/pnas.1323279111 3977243 F1000 Recommendation
42. Agrawal AS Garron T Tao X: Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol. 2015;89(7):3659-70. 25589660 10.1128/JVI.03427-14 4403411 F1000 Recommendation
43. Tao X Garron T Agrawal AS: Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease. J Virol. 2015;90(1):57-67. 26446606 10.1128/JVI.02009-15 4702581 F1000 Recommendation
44. Zhao G Jiang Y Qiu H: Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus. PLoS One. 2015;10(12):e0145561. 26701103 10.1371/journal.pone.0145561 4689477 F1000 Recommendation
45. Li K Wohlford-Lenane C Perlman S: Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4. J Infect Dis. 2016;213(5):712-22. 26486634 10.1093/infdis/jiv499 4747621 F1000 Recommendation
46. Pascal KE Coleman CM Mujica AO: Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2015;112(28):8738-43. 26124093 10.1073/pnas.1510830112 4507189 F1000 Recommendation
47. Coleman CM Sisk JM Halasz G: CD8 + T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017;91(1): pii: e01825-16. 27795435 10.1128/JVI.01825-16 5165197 F1000 Recommendation
48. Lamers MM Raj VS Shafei M: Deletion Variants of Middle East Respiratory Syndrome Coronavirus from Humans, Jordan, 2015. Emerging Infect Dis. 2016;22(4):716-9. 26981770 10.3201/eid2204.152065 4806954 F1000 Recommendation
49. Li K Wohlford-Lenane CL Channappanavar R: Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A. 2017;114(15):E3119-E3128. 28348219 10.1073/pnas.1619109114 5393213 F1000 Recommendation
50. Kindler E Jónsdóttir HR Muth D: Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio. 2013;4(1):e00611-12. 23422412 10.1128/mBio.00611-12 3573664
51. Chan RW Chan MC Agnihothram S: Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol. 2013;87(12):6604-14. 23552422 10.1128/JVI.00009-13 3676115
52. Zielecki F Weber M Eickmann M: Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol. 2013;87(9):5300-4. 23449793 10.1128/JVI.03496-12 3624328
53. Rabouw HH Langereis MA Knaap RC: Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses. PLoS Pathog. 2016;12(10):e1005982. 27783669 10.1371/journal.ppat.1005982 5081173 F1000 Recommendation
54. Menachery VD Eisfeld AJ Schäfer A: Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. mBio. 2014;5(3):e01174-14. 24846384 10.1128/mBio.01174-14 4030454
55. Lokugamage KG Narayanan K Nakagawa K: Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin. J Virol. 2015;89(21):10970-81. 26311885 10.1128/JVI.01352-15 4621111 F1000 Recommendation
56. Bailey-Elkin BA Knaap RC Johnson GG: Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem. 2014;289(50):34667-82. 25320088 10.1074/jbc.M114.609644 4263872
57. Mielech AM Kilianski A Baez-Santos YM: MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology. 2014;450-451:64-70. 24503068 10.1016/j.virol.2013.11.040 3957432
58. Yang Y Zhang L Geng H: The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell. 2013;4(12):951-61. 24318862 10.1007/s13238-013-3096-8 4875403
59. Lui PY Wong LY Fung CL: Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerg Microbes Infect. 2016;5(4):e39. 27094905 10.1038/emi.2016.33 4855074 F1000 Recommendation
60. Siu KL Yeung ML Kok KH: Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol. 2014;88(9):4866-76. 24522921 10.1128/JVI.03649-13 3993821
61. Niemeyer D Zillinger T Muth D: Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol. 2013;87(22):12489-95. 24027320 10.1128/JVI.01845-13 3807936
62. Matthews KL Coleman CM van der Meer Y: The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. J Gen Virol. 2014;95(Pt 4):874-82. 24443473 10.1099/vir.0.062059-0 3973478
63. Yang Y Ye F Zhu N: Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci Rep. 2015;5: 17554. 26631542 10.1038/srep17554 4668369 F1000 Recommendation
64. Thornbrough JM Jha BK Yount B: Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation. mBio. 2016;7(2):e00258. 27025250 10.1128/mBio.00258-16 4817253
65. Zhao L Jha BK Wu A: Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe. 2012;11(6):607-16. 22704621 10.1016/j.chom.2012.04.011 3377938 F1000 Recommendation
66. Hemida MG Perera RA Wang P: Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill. 2013;18(50):20659. 24342517 10.2807/1560-7917.ES2013.18.50.20659
67. Munster VJ Adney DR van Doremalen N: Replication and shedding of MERS-CoV in Jamaican fruit bats ( Artibeus jamaicensis). Sci Rep. 2016;6: 21878. 26899616 10.1038/srep21878 4761889 F1000 Recommendation
68. Adney DR van Doremalen N Brown VR: Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerging Infect Dis. 2014;20(12):1999-2005. 25418529 10.3201/eid2012.141280 4257817
69. Khalafalla AI Lu X Al-Mubarak AI: MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013-2014. Emerging Infect Dis. 2015;21(7):1153-8. 26079346 10.3201/eid2107.150070 4480395
70. Haagmans BL van den Brand JM Raj VS: An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science. 2016;351(6268):77-81. 26678878 10.1126/science.aad1283